Based on current analysis, Aarey Drugs & Pharmaceuticals Ltd receives a 'Strong Sell' recommendation as of November 28, 2025. This evaluation considers the company's overall health and recent trends as of April 6, 2026. Investors may want to reconsider their holdings in this stock.

Aarey Drugs shares reached a high of 4.45% upper circuit on April 6, 2026, closing at Rs 56.39. This surge in price indicates strong buyer interest with no sellers participating in the market.